Model
Edge
Lyell Immunopharma Inc.
0001866154
Filing type
4
Filing date
Feb 10, 2026
Updated
Feb 11, 2026 ยท 7:05 PM
Copy reference
Filing
4
Statement of Changes in Beneficial Ownership